Vignesh Selvaprithiviraj

Dr. Vignesh Selvaprithiviraj is a biomaterials engineer specializing in hydrogel, injectable, and biopolymer formulations. He is currently a Postdoctoral Research Fellow at Rowan Group at the Australian Institute of Bioengineering and Nanotechnology (AIBN).

He has expertise in polymer processing, functionalization, and characterization of diverse biomaterial formulations for biomedical applications. He has worked extensively on biomaterials such as chitosan, gelatin methacrylate, carrageenan, hyaluronic acid, and bioceramics such as hydroxyapatite and whitlockite. Previously, he has collaborated with pharmaceutical companies such as Pfizer and Stelis Biopharma, supporting their R&D of injectable formulations. He has also mentored master’s thesis works focusing on injectable gels and formulation of bio-inks.

Vignesh’s doctoral thesis at UQ School of Dentistry focused on developing injectable hydrogels for soft tissue expansion and bone regeneration. Vignesh did his placement at Gelomics 3D cell culture technologies, where he later worked as an R&D scientist. He was involved in the R&D of the company’s different product portfolios. He also worked as a Postdoctoral Research Fellow at Advanced Spinifex Biofutures Materials Centre- Spinifex Materials for Biomedical Applications, Trioda Wilingi, established in partnership with Bulugudu Limited.